1. No category

Lipid Management Beyond Statins: Biologic Basis,
New Clinical Evidence, and Strategies
Complimentary
CME/CE
Dinner
Friday, June 12, 2015
6:30 pm – 7:00 pm
7:00 pm – 9:15 pm
Registration and Dinner
CME/CE Activity
Palmer House Hilton
State Ballroom, 4th Floor
17 East Monroe Street
Chicago, IL 60603
This activity is jointly provided by Postgraduate Institute for Medicine
This activity is jointly provided by the National Lipid Association.
Medtelligence
SM
Supported by an educational grant from Amarin Pharma Inc.
Program Overview
Statins provide proven cardiovascular benefit in broad patient categories. Yet, even with guideline-mandated statin
management, substantial residual risk remains for many dyslipidemic patients. Fibrates, nicotinic acids, OM3s,
cholesterol absorption inhibitors? What is the biologic plausibility of each class for cardiovascular benefit? What
is the clinical evidence? Are there agents of choice for particular forms of dyslipidemia? How much might severity
of dyslipidemia or co-morbidities such as CAD, diabetes, or obesity factor into decision-making? This engaging
educational activity will provide a rigorous review of these questions with an emphasis on offering expert practical
commentary for clinicians who treat patients at high risk for CV events.
Target Audience
Physicians, NPs/PAs, pharmacists, RNs, Advance Practice Registered Nurses, and
registered dietitians with an interest in lipid management and CV disease risk reduction
Learning Objectives
After completing this activity, the participant should be better able to:
• Relate the key biologic pathways responsible for atherosclerotic disease and the
mechanisms of therapies that inhibit its development
• Discuss the current clinical trial evidence of therapies that have been used as add-on
therapy to statins to reduce CV events
• Incorporate risk assessment, guideline recommendations, and patient-centered
approaches for add-on therapeutic decision-making for patients at high risk for CV events
• For Registered Nurses and Nurse Practitioners only:
– Provide appropriate care and counsel for patients and their families
Friday, June 12, 2015
Palmer House Hilton
6:30 pm – 7:00 pm
7:00 pm – 9:15 pm
State Ballroom, 4th Floor
17 East Monroe Street, Chicago, IL 60603
Registration and Dinner
CME/CE Activity
Agenda
6:30 pm
Registration and Dinner
7:00
Welcome and Opening Remarks
Peter Libby, MD, Chair
7:10
Mechanistic Insights Into Treatments to Reduce
Atherosclerosis Beyond Statins
Peter Libby, MD
7:35
The Evidence for Add-on to Statin Therapy to
Reduce CV Events
Michael Miller, MD
8:00
Risk, Evidence, and Patient Preference in
Guiding Add-on Therapy
Harold Bays, MD
8:25
Panel Discussion and Q&A
All Faculty
8:45
Cases for Discussion
All Faculty
9:15 pm
Adjourn
Lipid Management Beyond Statins: Biologic Basis,
New Clinical Evidence, and Strategies
Faculty
Peter Libby, MD, FACC, Chair
Cardiovascular Medicine
Brigham and Women’s Hospital
Mallinckrodt Professor of Medicine
Harvard Medical School
Boston, MA
Harold E. Bays, MD, FTOS, FACC, FACE, FNLA
Medical Director / President
L-MARC Research Center
Louisville, KY
Michael Miller, MD, FACC, FAHA
Professor of Cardiovascular Medicine, Epidemiology & Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Baltimore, MD
Attendance Is Limited!
Registration for this event must be submitted online at:
http://events.medtelligence.net/nla2015.html
Credit Designation
CME credit provided by the National Lipid Association
Physicians
This activity has been planned and implemented in accordance with the accreditation
requirements and policies of the Accreditation Council for Continuing Medical
Education (ACCME) through the joint providership of the National Lipid Association
and Medtelligence. The National Lipid Association is accredited by the ACCME to
provide continuing medical education for physicians.
The National Lipid Association designates this live activity for a maximum of 2.25
AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate
with the extent of their participation in the activity.
Physician Assistants
NCCPA accepts AMA PRA Category I Credit ™ from organizations accredited
by ACCME.
Dietitians
The National Lipid Association is a Continuing Professional Education (CPE)
Accredited Provider with the Commission on Dietetic Registration (CDR). CDR
Credentialed Practitioners will receive 2 Continuing Professional Education Units
(CPEUs) for completion of this program. CDR Accredited Provider #NL0002.
CE credit provided by Postgraduate Institute for Medicine
Pharmacists
Postgraduate Institute for Medicine is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
Universal Activity Number 0809-9999-185-L01-P (Application)
Postgraduate Institute for Medicine designates this continuing education activity for
2.25 contact hours (.225 CEUs) of the Accreditation Council for Pharmacy Education.
Nursing
This educational activity for 2.0 contact hours is provided by Postgraduate Institute
for Medicine.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing
education by the American Nurses Credentialing Center’s Commission on Accreditation.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Criteria for Success
Statements of credit will be awarded based on the participant’s attendance at
each session and submission of the activity evaluation form. A statement of credit
will be available upon completion of an online evaluation/claimed credit form
at www.lipid.org/cme. If you have questions about this CME/CE activity,
please contact the NLA at [email protected]. Please claim credit by July 10, 2015.
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript
information will be available at www.mycpemonitor.net within 4 weeks.
Disclosure Statement
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor,
and integrity in all of its continuing education activities. The faculty must disclose to
the participants any significant relationships with commercial interests whose products
or devices may be mentioned in the activity or with the commercial supporter of this
continuing education activity. Identified conflict of interest is resolved by NLA prior
to accreditation of the activity. NLA planners and reviewers have no relevant financial
relationships to disclose.
Commercial Support
Full notification of commercial support will be provided in the activity syllabus.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical,
dietary, etc). Please contact Chris Archibald prior to the live event at
[email protected].
There is no fee for this educational activity.